Search for putative suppressor genes in meningioma: significance of chromosome 22
- PMID: 1551661
- DOI: 10.1007/BF00219348
Search for putative suppressor genes in meningioma: significance of chromosome 22
Abstract
Cytogenetic and molecular studies of various solid tumors have indicated that a series of different chromosomal regions may be deleted in the tumor genome. Usually, losses of heterozygosity are observed and, from this finding, the presence of specific genes acting as tumor suppressors has been deduced. In particular tumors, however, only a single chromosome site appears to be affected. Therefore, we have carried out a study of human meningioma, investigating 7 such putative suppressor regions by applying twelve site-specific DNA markers. In 6 out of 19 tumors, we exclusively found loss of heterozygosity for markers of the long arm of chromosome 22; none of the tumors showed statistically significant additional allelic losses for the regions 1p, 3p, 5p, 5q, 11p, 13q, 17p. Our data support the long-standing observation that only losses of or within chromosome 22 are associated with the development of meningiomas. Other suppressor regions are apparently not involved.
Similar articles
-
Loss of heterozygosity on chromosome 22q and 17p correlates with aggressiveness of meningiomas.J Neurooncol. 1998 Nov;40(2):101-6. doi: 10.1023/a:1006110812240. J Neurooncol. 1998. PMID: 9892091
-
Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.Clin Cancer Res. 2003 Oct 1;9(12):4435-42. Clin Cancer Res. 2003. PMID: 14555516
-
1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization.Genes Chromosomes Cancer. 1997 Dec;20(4):419-24. Genes Chromosomes Cancer. 1997. PMID: 9408760
-
Analysis of chromosome 22 loci in meningioma. Alterations in the leukemia inhibitory factor (LIF) locus.Mol Chem Neuropathol. 1994 Feb-Apr;21(2-3):189-217. doi: 10.1007/BF02815351. Mol Chem Neuropathol. 1994. PMID: 7916188 Review.
-
The molecular genetics of meningiomas.Brain Pathol. 1990 Sep;1(1):19-24. doi: 10.1111/j.1750-3639.1990.tb00634.x. Brain Pathol. 1990. PMID: 1688296 Review.
Cited by
-
Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis.Cancers (Basel). 2023 Nov 9;15(22):5339. doi: 10.3390/cancers15225339. Cancers (Basel). 2023. PMID: 38001599 Free PMC article. Review.
-
Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas.Hum Genet. 1996 May;97(5):632-7. doi: 10.1007/BF02281874. Hum Genet. 1996. PMID: 8655144
-
Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas.Hum Genet. 1995 Mar;95(3):347-51. doi: 10.1007/BF00225206. Hum Genet. 1995. PMID: 7868131
-
Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses.Am J Pathol. 1994 Jun;144(6):1203-18. Am J Pathol. 1994. PMID: 8203461 Free PMC article.
-
Diagnostic challenges in meningioma.Neuro Oncol. 2017 Nov 29;19(12):1588-1598. doi: 10.1093/neuonc/nox101. Neuro Oncol. 2017. PMID: 28531331 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources